Literature DB >> 30204536

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

Ethan Basch1, Amylou C Dueck1, Lauren J Rogak1, Sandra A Mitchell1, Lori M Minasian1, Andrea M Denicoff1, Jennifer K Wind1, Mary C Shaw1, Narre Heon1, Qian Shi1, Brenda Ginos1, Garth D Nelson1, Jeffrey P Meyers1, George J Chang1, Harvey J Mamon1, Martin R Weiser1, Tatjana Kolevska1, Bryce B Reeve1, Deborah Watkins Bruner1, Deborah Schrag1.   

Abstract

Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable patient reporting of symptomatic adverse events in oncology clinical research. This study was designed to assess the feasibility and resource requirements associated with implementing PRO-CTCAE in a multicenter trial. Methods Patients with locally advanced rectal cancer enrolled in the National Cancer Institute-sponsored North Central Cancer Treatment Group (Alliance) Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and Total Mesorectal Excision trial were asked to self-report 30 PRO-CTCAE items weekly from home during preoperative therapy, and every 6 months after surgery, via either the Web or an automated telephone system. If participants did not self-report within 3 days, a central coordinator called them to complete the items. Compliance was defined as the proportion of participants who completed PRO-CTCAE assessments at expected time points. Results The prespecified PRO-CTCAE analysis was conducted after the 500th patient completed the 6-month follow-up (median age, 56 years; 33% female; 12% nonwhite; 43% high school education or less; 5% Spanish speaking), across 165 sites. PRO-CTCAE was reported by participants at 4,491 of 4,882 expected preoperative time points (92.0% compliance), of which 3,771 (77.2%) were self-reported by participants and 720 (14.7%) were collected via central coordinator backup. Compliance at 6-month post-treatment follow-up was 333 of 468 (71.2%), with 122 (26.1%) via backup. Site research associates spent a median of 15 minutes on PRO-CTCAE work for each patient visit. Work by a central coordinator required a 50% time commitment. Conclusion Home-based reporting of PRO-CTCAE in a multicenter trial is feasible, with high patient compliance and low site administrative requirements. PRO-CTCAE data capture is improved through centralized backup calls.

Entities:  

Year:  2018        PMID: 30204536      PMCID: PMC6209091          DOI: 10.1200/JCO.2018.78.8620

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  9 in total

1.  Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Amylou C Dueck; Tito R Mendoza; Sandra A Mitchell; Bryce B Reeve; Kathleen M Castro; Lauren J Rogak; Thomas M Atkinson; Antonia V Bennett; Andrea M Denicoff; Ann M O'Mara; Yuelin Li; Steven B Clauser; Donna M Bryant; James D Bearden; Theresa A Gillis; Jay K Harness; Robert D Siegel; Diane B Paul; Charles S Cleeland; Deborah Schrag; Jeff A Sloan; Amy P Abernethy; Deborah W Bruner; Lori M Minasian; Ethan Basch
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

2.  Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Authors:  Ethan Basch; Bryce B Reeve; Sandra A Mitchell; Steven B Clauser; Lori M Minasian; Amylou C Dueck; Tito R Mendoza; Jennifer Hay; Thomas M Atkinson; Amy P Abernethy; Deborah W Bruner; Charles S Cleeland; Jeff A Sloan; Ram Chilukuri; Paul Baumgartner; Andrea Denicoff; Diane St Germain; Ann M O'Mara; Alice Chen; Joseph Kelaghan; Antonia V Bennett; Laura Sit; Lauren Rogak; Allison Barz; Diane B Paul; Deborah Schrag
Journal:  J Natl Cancer Inst       Date:  2014-09-29       Impact factor: 13.506

3.  Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.

Authors:  Ethan Basch; Allison M Deal; Amylou C Dueck; Howard I Scher; Mark G Kris; Clifford Hudis; Deborah Schrag
Journal:  JAMA       Date:  2017-07-11       Impact factor: 56.272

Review 4.  What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials.

Authors:  Grigorios Kotronoulas; Nora Kearney; Roma Maguire; Alison Harrow; David Di Domenico; Suzanne Croy; Stephen MacGillivray
Journal:  J Clin Oncol       Date:  2014-04-07       Impact factor: 44.544

5.  Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.

Authors:  Ethan Basch; Stephanie L Pugh; Amylou C Dueck; Sandra A Mitchell; Lawrence Berk; Shannon Fogh; Lauren J Rogak; Marcha Gatewood; Bryce B Reeve; Tito R Mendoza; Ann M O'Mara; Andrea M Denicoff; Lori M Minasian; Antonia V Bennett; Ann Setser; Deborah Schrag; Kevin Roof; Joan K Moore; Thomas Gergel; Kevin Stephans; Andreas Rimner; Albert DeNittis; Deborah Watkins Bruner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-02-10       Impact factor: 7.038

6.  Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Jennifer L Hay; Thomas M Atkinson; Bryce B Reeve; Sandra A Mitchell; Tito R Mendoza; Gordon Willis; Lori M Minasian; Steven B Clauser; Andrea Denicoff; Ann O'Mara; Alice Chen; Antonia V Bennett; Diane B Paul; Joshua Gagne; Lauren Rogak; Laura Sit; Vish Viswanath; Deborah Schrag; Ethan Basch
Journal:  Qual Life Res       Date:  2013-07-20       Impact factor: 4.147

7.  Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.

Authors:  Ethan Basch; William A Wood; Deborah Schrag; Camelia S Sima; Mary Shaw; Lauren J Rogak; Mark G Kris; Marwan Shouery; Antonia Bennett; Thomas Atkinson; M Catherine Pietanza
Journal:  Clin Trials       Date:  2015-11-04       Impact factor: 2.486

Review 8.  Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data.

Authors:  Ethan Basch; Amylou C Dueck
Journal:  Expert Opin Drug Discov       Date:  2016-06-16       Impact factor: 6.098

9.  Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Authors:  Antonia V Bennett; Amylou C Dueck; Sandra A Mitchell; Tito R Mendoza; Bryce B Reeve; Thomas M Atkinson; Kathleen M Castro; Andrea Denicoff; Lauren J Rogak; Jay K Harness; James D Bearden; Donna Bryant; Robert D Siegel; Deborah Schrag; Ethan Basch
Journal:  Health Qual Life Outcomes       Date:  2016-02-19       Impact factor: 3.186

  9 in total
  22 in total

1.  Digitalization in Medicine: It Is Our Chance and Responsibility Now to Shape the Digital Future of Breast Cancer Management.

Authors:  Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2019-06-03       Impact factor: 2.860

2.  Performance Status in Cancer: Not Broken, But Time for an Upgrade?

Authors:  Jessica M Scott; Guro Stene; Elisabeth Edvardsen; Lee W Jones
Journal:  J Clin Oncol       Date:  2020-06-25       Impact factor: 44.544

3.  Patient-Reported Outcomes in Surgical Oncology: An Overview of Instruments and Scores.

Authors:  Joseph D Phillips; Sandra L Wong
Journal:  Ann Surg Oncol       Date:  2019-08-28       Impact factor: 5.344

4.  Is "Geriatric" Assessment Just for Older Patients?

Authors:  Gabriel F P Aleixo; Seul Ki Choi; Alyssa J Tan; Kirsten A Nyrop; Alyson M Deal; William A Wood; Trevor A Jolly; Hyman B Muss
Journal:  Oncologist       Date:  2019-09-13

5.  ASO Author Reflections: Patient-Reported Outcomes-Bench to Bedside.

Authors:  Srinivas Joga Ivatury; Sandra L Wong; Deborah Schrag
Journal:  Ann Surg Oncol       Date:  2019-11-18       Impact factor: 5.344

6.  Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303.

Authors:  Jennifer S Temel; Jeff Sloan; Tyler Zemla; Joseph A Greer; Vicki A Jackson; Areej El-Jawahri; Mihir Kamdar; Arif Kamal; Craig D Blinderman; Jacob Strand; Dylan Zylla; Christopher Daugherty; Muhummad Furqan; Jennifer Obel; Mohammad Razaq; Eric J Roeland; Charles Loprinzi
Journal:  J Palliat Med       Date:  2020-02-07       Impact factor: 2.947

7.  Is "Geriatric" Assessment Just for Older Patients?

Authors:  Gabriel F P Aleixo; Seul Ki Choi; Alyssa J Tan; Kirsten A Nyrop; Alyson M Deal; William A Wood; Trevor A Jolly; Hyman B Muss
Journal:  Oncologist       Date:  2019-09-13

8.  Completion of Patient-Reported Outcome Questionnaires Among Older Adults with Advanced Cancer.

Authors:  Marie A Flannery; Supriya Mohile; Eva Culakova; Sally Norton; Charles Kamen; J Nicholas Dionne-Odom; Grace DiGiovanni; Lorraine Griggs; Thomas Bradley; Judith O Hopkins; Jane Jijun Liu; Kah Poh Loh
Journal:  J Pain Symptom Manage       Date:  2021-08-08       Impact factor: 3.612

9.  Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer.

Authors:  Kaitlyn Lapen; Christopher Sabol; Amy L Tin; Kathleen Lynch; Alyse Kassa; Xiaolin Mabli; John Ford; Elaine Cha; Michael B Bernstein; Lior Z Braunstein; Oren Cahlon; Bobby M Daly; Kiri Sandler; Susan A McCloskey; Andrew J Vickers; Atif J Khan; Erin F Gillespie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-07-24       Impact factor: 7.038

10.  Electronic Patient Reporting of Adverse Events and Quality of Life: A Prospective Feasibility Study in General Oncology.

Authors:  Fiona Kennedy; Kate Absolom; Beverly Clayton; Zoe Rogers; Kathryn Gordon; Elaine O'Connell Francischetto; Jane M Blazeby; Julia Brown; Galina Velikova
Journal:  JCO Oncol Pract       Date:  2020-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.